Nutriband Inc. (NTRB)
NASDAQ: NTRB · IEX Real-Time Price · USD
7.24
+0.82 (12.77%)
At close: Jul 19, 2024, 4:00 PM
7.25
+0.01 (0.14%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Nutriband Revenue
Nutriband had revenue of $2.02M in the twelve months ending April 30, 2024. Revenue in the quarter ending April 30, 2024 was $408.53K. In the fiscal year ending January 31, 2024, Nutriband had annual revenue of $2.09M with 0.27% growth.
Revenue (ttm)
$2.02M
Revenue Growth
-2.97%
P/S Ratio
39.62
Revenue / Employee
$155,147
Employees
13
Market Cap
79.90M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jan 31, 2024 | 2.09M | 5.71K | 0.27% |
Jan 31, 2023 | 2.08M | 657.46K | 46.23% |
Jan 31, 2022 | 1.42M | 478.45K | 50.70% |
Jan 31, 2021 | 943.70K | 573.06K | 154.61% |
Jan 31, 2020 | 370.65K | 125.36K | 51.11% |
Jan 31, 2019 | 245.29K | - | - |
Jan 31, 2018 | 0 | - | - |
Jan 31, 2017 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SCYNEXIS | 140.39M |
Protalix BioTherapeutics | 59.65M |
Marinus Pharmaceuticals | 28.29M |
Ikena Oncology | 3.85M |
Chimerix | 41.00K |
NTRB News
- 3 days ago - Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25 - Accesswire
- 7 days ago - Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology - Accesswire
- 4 weeks ago - Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl - Accesswire
- 7 weeks ago - Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year - Accesswire
- 2 months ago - Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors - Accesswire
- 2 months ago - Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 3 months ago - Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group - Accesswire
- 3 months ago - Nutriband Inc. Announces $8.4M Private Placement - Accesswire